Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Current-Deferred-Revenue" stands at 69.78 Billion Japanese Yens as of 06/30/2025, the highest value since 06/30/2018.
As of the end of Daiichi Sankyo Co. Ltd.'s first quarter, the item "Current Deferred Revenue" stands at 69.78 Billion JPY. This represents an increase of 2.69 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 22.49 percent compared to the value the year prior.
The 1 year change in percent is 22.49.
The 3 year change in percent is 179.23.
The 5 year change in percent is 144.54.
The 10 year change in percent is 143.46.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |